Ultrasound reveals hidden stomach risks in semaglutide users
NCT ID NCT06292065
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study used bedside ultrasound to see if people taking semaglutide (Ozempic, Wegovy) have more food or liquid in their stomachs before surgery, despite fasting. Researchers compared 88 adults on semaglutide to those not taking it. The goal was to help anesthesiologists decide if it's safe to proceed with anesthesia or if changes are needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide
- What this could lead to
- If successful, this could help doctors make safer anesthesia decisions for patients on semaglutide by better predicting stomach fullness.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Could a botox shot in the gut ease Kids' chronic vomiting?
- Can writing poetry ease anxiety for those with stomach disorders?
- Tracking a promising therapy for stomach paralysis
- New MRI technique could shed light on stomach disorder
- Can a stomach biopsy predict who will respond to gastric pacemakers?